GLI1 and ovarian serous adenocarcinoma: In the present study we investigated the prognostic role of Gli1 in a homogenous population of advanced serous ovarian cancers showing that patients whose tumors express nuclear Gli1 staining (>10%) experience a shorter OS compared to negative cases (≤10%).